Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

CAR-T Meeting 2021 | The major hurdles and emerging opportunities of CAR T-cell therapy

Sara Ghorashian • 4 Feb 2021
CAR-T Meeting 2021
General CAR-T

Sara Ghorashian, PhD, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK, outlines the remaining challenges in the CAR T-cell therapy space. CAR-T therapy is a revolutionary treatment, but numerous obstacles must be overcome to unlock the full potential of CAR-T. Additionally, Dr Ghoashian highlights that the biological principles of these cells need to be better understood to find improved solutions to meet the patients’ needs. This interview took place during the 3rd European CAR T-cell Meeting.

Disclosures

Honoraria: Novartis
Patents, royalties: UCLB

More from Sara Ghorashian

Exciting updates in ALL and the value of novel immunotherapies
1:11
Exciting updates in ALL and the value of novel immunotherapies
Sara Ghorashian • 11 Dec 2022
Evaluating dual-targeting CD19/22 CAR-T cells in patients with R/R ALL
3:18
Evaluating dual-targeting CD19/22 CAR-T cells in patients with R/R ALL
Sara Ghorashian • 11 Dec 2022
Analysis of real-world outcomes in patients with B-ALL receiving tisagenlecleucel
2:18
Analysis of real-world outcomes in patients with B-ALL receiving tisagenlecleucel
Sara Ghorashian • 11 Dec 2022
Managing relapse after CAR-T therapy in ALL
1:20
Managing relapse after CAR-T therapy in ALL
Sara Ghorashian • 12 Jun 2022

Related Videos

The ethical challenges of AI in hematology: patient communication, trust and regulation
3:12
The ethical challenges of AI in hematology: patient communication, trust and regulation
Adrián Mosquera Orgueira • 24 Sep 2026
The future of AI in hematology: personalized medicine, opportunities and risks
2:30
The future of AI in hematology: personalized medicine, opportunities and risks
Adrián Mosquera Orgueira • 24 Sep 2026
The multi-system impacts of CHIP and its link to subspecialties within internal medicine
5:18
The multi-system impacts of CHIP and its link to subspecialties within internal medicine
Shyam Patel • 13 Oct 2026
The scientific and clinical implications of therapy-related CHIP in oncology
2:43
The scientific and clinical implications of therapy-related CHIP in oncology
Shyam Patel • 13 Oct 2026

Choose your cookie settings

VJHemOnc uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJHemOnc is intended for healthcare professionals